| Financial Year |
March 31 2023 |
| Monetary Funds |
829,642,400.49 |
| Held-for-trading Financial Assets |
452,179.67 |
| Notes Receivable |
25,134,423.60 |
| Accounts Receivable |
590,630,942.13 |
| Advances to Suppliers |
15,867,771.73 |
| Other Receivables |
30,735,360.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
515,945,874.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,951,090.06 |
| Total Current Assets |
2,302,549,799.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,913,959.39 |
| Investment Properties |
1,149,319.89 |
| Fixed Assetes |
736,837,571.99 |
| Under-construction Projects |
68,509,113.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,159,422.19 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,686,129.72 |
| Deferred Income Tax Assets |
12,427,623.85 |
| Other Non-Current Assets |
73,204,880.19 |
| Sub-Total of Non-Current Assets |
1,269,584,485.25 |
| Total Assets |
3,572,134,284.72 |
| Short-Term Loans |
26,030,711.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
435,120,000.00 |
| Accounts Payable |
340,944,178.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,633,735.39 |
| Taxes Payable |
21,927,363.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
40,958,688.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,585,310.38 |
| Other Current Liabilities |
12,337,973.57 |
| Sub-Total of Current Liabilities |
990,241,058.70 |
| Long-term Loans |
-- |
| Bonds Payable |
503,955,507.23 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
592,170.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
553,770,992.32 |
| Total Liabilities |
1,544,012,051.02 |
| Paid-In Capital(Or Share Stock) |
411,574,346.00 |
| Capital Surplus |
568,025,080.54 |
| Surplus Reserve |
184,985,200.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
832,241,234.89 |
| Minority Stockholder's Interest |
9,884,650.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,018,237,583.28 |
| Owner's Equity（Stockholder's Equity） |
2,028,122,233.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,572,134,284.72 |
